Reliq Health Technologies Inc.

DB:MHN2 Stock Report

Market Cap: €32.3m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Reliq Health Technologies Past Earnings Performance

Past criteria checks 0/6

Reliq Health Technologies has been growing earnings at an average annual rate of 95.1%, while the Healthcare Services industry saw earnings growing at 2.2% annually. Revenues have been growing at an average rate of 119.4% per year.

Key information

95.1%

Earnings growth rate

95.2%

EPS growth rate

Healthcare Services Industry Growth7.9%
Revenue growth rate119.4%
Return on equity-3.4%
Net Margin-3.1%
Last Earnings Update31 Mar 2023

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Reliq Health Technologies makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:MHN2 Revenue, expenses and earnings (CAD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 2315073
31 Dec 2212-264
30 Sep 2210-483
30 Jun 229-8112
31 Mar 227-9122
31 Dec 215-11131
30 Sep 213-13141
30 Jun 211-12112
31 Mar 211-11101
31 Dec 201-11101
30 Sep 201-1192
30 Jun 201-1192
31 Mar 201-14103
31 Dec 191-14104
30 Sep 190-1284
30 Jun 190-1385
31 Mar 190-17124
31 Dec 181-18144
30 Sep 182-16143
30 Jun 182-14131
31 Mar 182-771
31 Dec 171-331
30 Sep 170-331
30 Jun 170-221
31 Mar 170-321
31 Dec 160-320
30 Sep 161-320
30 Jun 161-320
31 Mar 161-330
31 Dec 150-530
30 Sep 150-520
30 Jun 150-520
31 Mar 150-410
30 Sep 140-110
30 Jun 140-100
30 Jun 130-101

Quality Earnings: MHN2 is currently unprofitable.

Growing Profit Margin: MHN2 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if MHN2's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Unable to compare MHN2's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: MHN2 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (-12.8%).


Return on Equity

High ROE: MHN2 has a negative Return on Equity (-3.41%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/04/15 07:27
End of Day Share Price 2024/01/17 00:00
Earnings2023/03/31
Annual Earnings2022/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Reliq Health Technologies Inc. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Gabriel LeungBeacon Securities Limited
Allen KleeMaxim Group
David KwanVentum Financial Corp